Join to View Full Profile
28815 8 Mile RdSuite 103Livonia, MI 48152
Phone+1 248-478-6806
Fax+1 248-478-6908
Are you Dr. Ferguson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gary Ferguson, MD is a pulmonologist in Livonia, Michigan. He is currently licensed to practice medicine in Michigan, Florida, and Colorado.
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
University of WashingtonResidency, Internal Medicine, 1980 - 1983- University of Washington School of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 2021 - 2027
MI State Medical License 1995 - 2026
CO State Medical License 1986 - 1999
NM State Medical License 1986 - 1989
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 3 citationsAccess to Lung Cancer Screening Among American Indian and Alaska Native Adults: A Qualitative Study.Allison C Welch, Sara M London, Candice L Wilshire, Christopher R Gilbert, Dedra Buchwald
Chest. 2024-03-01 - 3 citationsClinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone ...Sanjay Sethi, Swetha R Palli, Lindsay G S Bengtson, Erin K Buysman, Brendan Clark
Journal of Managed Care & Specialty Pharmacy. 2023-07-01 - Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease.James F Donohue, Gary T Ferguson, Jill A Ohar, David A Lombardi, Roslyn F Schneider
Respiratory Medicine. 2023-03-01
Press Mentions
Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023May 2nd, 2023- CHEST: ETHOS Sub-Analysis Confirms Triple Therapy BenefitOctober 23rd, 2020
